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Abstract
We determined the response characteristics and functional correlates of the dynamic relationship between the rate (Δ) of oxygen 
consumption ( O2) and the applied power output (work rate = WR) during ramp-incremental exercise in patients with mitochon-
drial myopathy (MM). Fourteen patients (7 males, age 35.4 ± 10.8 years) with biopsy-proven MM and 10 sedentary controls (6 
males, age 29.0 ± 7.8 years) took a ramp-incremental cycle ergometer test for the determination of the O2 on-exercise mean 
response time (MRT) and the gas exchange threshold (GET). The Δ O2/ΔWR slope was calculated up to GET (S1), above GET 
(S2) and over the entire linear portion of the response (ST). Knee muscle endurance was measured by isokinetic dynamometry. 
As expected, peak O2 and muscle performance were lower in patients than controls (P < 0.05). Patients had significantly 
lower Δ O2/ΔWR than controls, especially the S2 component (6.8 ± 1.5 vs 10.3 ± 0.6 mL·min-1·W-1, respectively; P < 0.001). 
There were significant relationships between Δ O2/ΔWR (ST) and muscle endurance, MRT- O2, GET and peak O2 in MM 
patients (P < 0.05). In fact, all patients with Δ O2/ΔWR below 8 mL·min-1·W-1 had severely reduced peak O2 values (<60% 
predicted). Moreover, patients with higher cardiopulmonary stresses during exercise (e.g., higher Δ ventilation/carbon dioxide 
output and Δ heart rate/Δ O2) had lower Δ O2/ΔWR (P < 0.05). In conclusion, a readily available, effort-independent index of 
aerobic dysfunction during dynamic exercise (Δ O2/ΔWR) is typically reduced in patients with MM, being related to increased 
functional impairment and higher cardiopulmonary stress.
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The rate (Δ) of change in oxygen consumption ( O2) 
relative to power output (work rate, WR) during ramp-
incremental exercise depends on the ability of the cardio-
circulatory system to deliver, and the muscle capacity to 
extract, O2 from arterial (capillary) blood (1,2). The Δ O2/
ΔWR relationship is influenced by the gas exchange thresh-
old (GET) with most investigators describing a bi-linear 
response, i.e., a sub-GET S1 slope flatter than a supra-GET 
S2 slope (3-5). The analysis of the total Δ O2/ΔWR slope 
(ST) and its components can provide useful information 
about the adequacy of the aerobic responses to exercise 
in health and disease. Several studies, for instance, have 
shown that a flatter-than-normal Δ O2/ΔWR is a sensitive 
marker of abnormal O2 delivery and utilization in a number 
of systemic pathological conditions ranging from congestive 
heart failure to systemic lupus erythematosus (6-11).
Mitochondrial diseases are caused by very diverse 
genetic alterations located either on nuclear DNA or on 
mitochondrial DNA (mtDNA) (12). Mitochondrial myopathy 
(MM) is the collective term for disease conditions in which 
the diminished rate of cellular O2 utilization may place a 
burden on several systems in order to enhance O2 uptake 
and delivery (13-15). In fact, patients with MM commonly 
present hyperventilatory and hypercirculatory patterns of 
response to dynamic exercise (16-20). These abnormalities 
are likely to be related to the fundamental pathophysiologi-
cal abnormality in MM, i.e., impaired O2 extraction. In this 
context, although there is a sound physiological rationale 
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for the notion that Δ O2/ΔWR would be severely reduced 
in MM, and probably related to exercise impairment and 
to systemic cardiopulmonary stress, no previous study has 
investigated the characteristics and functional correlates of 
Δ O2/ΔWR (S1, S2, ST) in this patient population.
The objective of this study, therefore, was to compare the 
dynamic behavior of Δ O2/ΔWR during ramp-incremental 
exercise of patients with MM and that of healthy sedentary 
controls. We hypothesized that patients would present 
impaired O2 utilization (reduced Δ O2/ΔWR), which would 
be significantly related to maximum exercise capacity and 
selected indexes of functional impairment. In addition, we 
anticipated that the ventilatory and cardiovascular responses 
to the prevailing metabolic demand (21-23) would be in-
versely related to Δ O2/ΔWR, suggesting that the hyperki-
netic cardiopulmonary response would be mechanistically 
linked to impaired muscle bioenergetics in MM.
Material and Methods
Study population
Fourteen non-smoking patients (7 males aged 20 to 
52 years) with biopsy-proven MM (see below) who had 
been followed at the Institutional Neuromuscular Division 
agreed to participate in the study. All consecutive patients 
with the following characteristics were selected: clinical 
evidence of MM in the form of chronic progressive external 
ophthalmoplegia (13,17): ptosis, exercise intolerance, and 
chronic fatigue. This phenotype is associated with autosomal 
dominant DNA polymerase-gamma and adenine nucleotide 
translocase mutations with consequent deletions in mtDNA 
(15). There was no clinical or echocardiographic evidence 
of cardiomyopathy or impaired cardiac conduction in any 
patient. Subjects with mitochondrial encephalomyopathy, 
lactic acidosis and strokes, myoclonus epilepsy with 
ragged-red fibers, and other MMs were excluded from 
the study. In addition, to avoid the confounding effect of 
physical conditioning on muscle metabolism in MM (24), 
we selected patients who had not engaged in any regular 
physical activity in the preceding year.
Ten age- and gender-matched healthy volunteers (6 
males aged 20 to 46 years) comprised the control group. 
In order to match patients and controls for habitual physical 
activity, all study participants were required to present very 
low daily physical activity scores according to the Baecke 
questionnaire (total score <6) (25). The experimental pro-
tocol was approved by the Institutional Ethics Committee. 
However, muscle biopsies from normal subjects were not 
permitted. Written informed consent to participate was 
obtained from each subject.
Measurements
Body composition. Mid-arm circumference was mea-
sured and skin fold thickness at the bicipital and tricipital 
levels was obtained using a skin fold caliper: arm muscle 
circumference was derived from these readings (cm). 
Bioelectrical impedance (Quantum BIA-101Q, RJL-101™, 
USA) was used to estimate total body fat-free mass (FFM, 
kg); FFM index (FFMI) was calculated as the ratio of FFM 
to height in meters squared. 
Skeletal muscle biopsies. Percutaneous biopsies of 
the right vastus lateralis were obtained from its central 
region, 10-15 cm above the patella at mid-thigh level in 
patients. The biopsies were taken at least 3 months before 
the exercise test. Histopathological evaluation revealed a 
ragged-red fiber pattern in all specimens; abnormally low 
mitochondrial electron transport chain activity (cytochrome c 
oxidase) was demonstrated histochemically by the method 
of Seligman et al. (26). Two experienced neuropathologists 
independently reviewed the muscle biopsies.
Peripheral muscle strength. Isokinetic muscle endur-
ance of the dominant knee extensor (quadriceps) was 
measured with a computer-based dynamometer (Contrex 
CE, Switzerland). During the tests, subjects were seated 
upright on the chair of the dynamometer with their back 
fully supported. The mechanical axis of rotation of the 
lever arm was aligned to the axis of rotation of the knee. 
After a 3-min rest, muscle endurance was determined as 
the total work achieved during 20 consecutive maximal 
repetitions at 300º/s. 
Cardiopulmonary exercise testing. The exercise tests 
were carried out on an electromagnetically braked cycle er-
gometer (CPE 2000, Medical Graphics Corporation - MGC, 
USA) with gas exchange and ventilatory variables being 
analyzed breath-by-breath (CardiO2 System, MGC). The 
power (W) was continuously increased in a linear “ramp” 
pattern (27) (5-15 W/min in patients and 15-25 W/min in 
healthy subjects) so that the incremental exercise test 
duration was more than 8 min and less than 12 min in all 
participants, based on a “symptom-limited interruption”. The 
following variables are reported as means of 15 s: oxygen 
uptake ( O2, L/min at standard temperature and pressure 
dry, STPD), carbon dioxide output ( CO2, L/min STPD), 
minute ventilation ( E, L/min BTPS), and end-tidal partial 
pressure for O2 and CO2 (PETO2 and PETCO2, mmHg). 
Heart rate (HR, bpm) was automatically calculated from the 
R-R distance of a 12-lead ECG tracing (CardiO2 System, 
MGC). Capillary samples were collected from the ear lobe 
for blood lactate measurements (mEq/L) at exercise ces-
sation (Yellow Springs 2.700 STAT plus, Yellow Springs 
Instruments, USA). The samples were lysed before the 
measurements and values are reported as absolute values 
and related to peak WR (lactate/WR ratio). The O2 at 
the estimated lactate threshold was evaluated by the gas 
exchange method (GET), with visual inspection of the inflec-
tion point of CO2 with regard to O2 (modified V-slope) 
and by the ventilatory method when E/ O2 and PETO2 
increased while E/ CO2 and PETCO2 remained stable 
(28,29). The average O2 for the last 15 s was considered 
to be representative of the subject’s peak O2 (29).
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In order to measure the kinetics of the initial O2 adjust-
ment during the incremental exercise, the mean response 
time (MRT) was determined as the time from the onset of the 
ramp forcing function to the point of intersection between the 
baseline O2 and a linear backward extrapolation of the O2 
vs time slope (Figure 1) (30,31). This was performed in two 
ways, using either the region of O2 response below the GET, 
S1 (MRT1), or the total slope ST (MRTT) (27). The baseline 
was defined as the average value for O2 during the last 2 
min of unloaded cycling prior to onset of the ramp.
Submaximal exercise relationships. As mentioned, the 
Δ O2/ΔWR relationship (mL·min-1·W-1) was calculated to 
obtain an index of the overall gain of the O2 response, i.e., 
in disease states, reduced values would indicate a greater 
reliance on anaerobic sources of ATP regeneration (1,2). 
Considering that the GET could distort the linearity of the 
response (due to an even greater reliance on anaerobic 
metabolism) (3,5), the Δ O2/ΔWR slope was determined 
using linear regression analysis over three segments: S1, 
from the start of O2 increase during exercise to the GET; 
S2, from the GET to either peak O2 or where O2 began 
to level off, and ST, over the range of S1 + S2.
Determination of the ΔHR/Δ O2 relationship (beat· 
L-1·min-1). Although O2 is an appropriate dependent 
variable, this relationship has been traditionally described 
with HR on the y-axis (22,23). In this context, a steeper HR 
response to a given metabolic demand would imply reduced 
stroke volume and/or low peripheral oxygen extraction (i.e., 
an inappropriate cardiovascular response to incremental 
exercise). Linearity of the HR response throughout the test 
duration was first investigated for each subject. In the event 
of late departures from linearity, we then applied regression 
analysis only to the initial linear phase response.
Determination of the sub-respiratory compensation point 
(RCP) Δ E/Δ CO2 relationship. For the determination of 
this index of ventilatory “efficiency” (21-23), linear regression 
analysis was applied only to the individually selected data points 
below the RCP (i.e., before the development of the characteristic 
hyperventilatory response to the ongoing lactacidemia).
Statistical analysis
Means and standard deviations (SD) of normally dis-
tributed data (Kolmogorov-Smirnov test) were obtained 
for patients and controls and were compared using an 
unpaired t-test. Alternatively, the Mann-Whitney test was 
used to assess between-group differences of variables with 
a non-Gaussian distribution. Pearson’s product-moment 
correlation was used to assess the degree of association 
between continuous variables. The probability of a type I 
error was set at 5% for all tests (P < 0.05).
Results
Patient characteristics
Patients with MM presented decreased total body and 
fat-free mass indexes compared to normal subjects (P < 
0.05). Appendicular muscle mass, estimated by arm muscle 
circumference, was reduced in patients (Table 1). Muscle 
endurance capacity (total work) was also significantly lower 
in patients than controls (863.4 ± 274.2 vs 1577.5 ± 450.0 
kJ, respectively; P < 0.01). Peripheral muscle performance 
was related to fat-free mass index in MM patients (R = 
0.74; P < 0.001).
Metabolic responses to exercise
There were no significant between-group differences in 
Figure 1. Oxygen uptake ( O2) response to ramp-incremental 
exercise of a representative normal subject. Mean response time 
(MRT) of the kinetic response is calculated as the time from the 
onset of the ramp forcing function to the point of intersection be-
tween the baseline O2 and a linear backward extrapolation of 
the O2 vs time slope (30,31). 
Table 1. Resting characteristics of patients with mitochondrial 
myopathy and healthy controls.
Mitochondrial 
myopathy (N = 14)
Controls
(N = 10)
Demographic/anthropometric
Gender (male/female) 7/7 6/4
Age (years) 35.4 ± 10.8 29.0 ± 7.8
Height (m) 1.61 ± 0.83* 1.70 ± 0.64
Weight (kg) 52.9 ± 13.5* 71.4 ± 9.8
Body composition
BMI (kg/m2) 19.9 ± 3.9* 24.6 ± 2.9
FFM (kg) 40.3 ± 8.7* 52.5 ± 7.1
FFM index (kg/m2) 15.3 ± 2.3* 18.0 ± 2.0
AMC (cm) 20.5 ± 2.6* 24.9 ± 4.7
Data are reported as means ± SD. BMI = body mass index; FFM 
= fat free mass; AMC = arm muscle circumference. *P < 0.05 
(unpaired t-test).
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duration of the ramp forcing protocol (8.6 ± 1.1 vs 8.9 ± 1.9 
min for patients and controls, respectively; P > 0.05). Peak 
O2 and power (WR) were significantly lower in patients 
than controls (Table 2). The GET was noninvasively identi-
fied in all subjects and was lower in patients than controls 
when analyzed as mL/min and as % of predicted; however, 
since patients had lower weight, GET in mL·min-1·kg-1 was 
not significantly different. Also, patients had a lower capac-
ity to sustain exercise performance after the GET through 
peak O2, which was related to symptoms of leg pain and 
dyspnea. Therefore, the GET/ O2 peak ratio was higher 
in MM patients compared to controls. 
The Δ O2/ΔWR relationship could be described as 
a bi-linear function in all subjects, with the intersection 
point between S1 and S2 corresponding 
to the GET. Patients with MM presented 
lower S1, S2 and ST slopes than controls 
(P < 0.05; Table 2). However, the between-
group differences were more prominent in 
the S2 slope compared to S1 and ST (mean 
% reduction in MM patients compared to 
controls = 33.9, 17.8, and 25.2%, respec-
tively). Therefore, the ratio between the S2 
and S1 slopes was significantly lower in 
patients than controls (0.87 ± 0.15 vs 1.08 
± 0.18, P < 0.01). In addition, on-exercise 
O2 kinetics (MRT), considering either S1 
or ST, was slower in patients than controls 
(P < 0.05; Table 2).
Δ O2/ΔWR and functional impairment 
As shown in Figure 2, the overall Δ O2/
ΔWR response (i.e., ST) was significantly 
related to peak O2 in MM patients, but not 
in controls. In fact, all patients with Δ O2/
ΔWR below 8 mL·min-1·W-1 had severely 
reduced peak O2 (<60% predicted) (28). 
Patients with lower Δ O2/ΔWR presented 
reduced GET (r = 0.73) but higher WR-
corrected lactate and MRTT- O2 values 
(r = 0.69 and r = 0.76, respectively; P < 
0.01). Moreover, Δ O2/ΔWR was positively 
related to peripheral muscle endurance in 
MM patients (r = 0.78; P < 0.01) but not in 
controls (P > 0.05).
Relationship between Δ O2/ΔWR and 
cardiopulmonary responses in MM
Patients with MM had increased car-
diorespiratory responses to the metabolic 
demands during progressive exercise com-
pared to healthy controls (Table 2; P < 0.01) 
as previously described (16-20). There were 
significant inverse relationships between 
Δ O2/ΔWR (S1, S2 and ST) and submaximal 
cardiovascular (ΔHR/Δ O2) and ventilatory 
(Δ E/Δ CO2) responses in patients with 
MM (P < 0.05). The correlation coefficients, 
however, were higher for S2 than S1 and ST 
(S2 = -0.75 and -0.69; S1 = -0.51 and -0.55; 
ST = 0.60 and -0.62, for ΔHR/Δ O2 and 
Δ E/Δ CO2, respectively). 
Table 2. Cardiopulmonary exercise variables of patients with mitochondrial myo-
pathy and healthy controls.
Mitochondrial 
myopathy (N = 14)
Controls 
(N = 10)
POWER
Peak WR (W) 91 ± 31* 178 ± 38
METABOLIC
Peak exercise
O2 (mL·min-1·kg-1) 22.3 ± 7.2* 30.7 ± 6.0
O2 (% pred) 64 ± 21* 95 ± 15
RER 1.19 ± 0.15 1.20 ± 0.08
Lactate (mM) 7.2 ± 2.1 7.4 ± 1.4
Lactate/WR (mM/W) 0.07 (0.03-0.17)* 0.04 (0.03-0.06)
At the gas exchange threshold (GET)
O2 (mL/min) 705 ± 274* 1006 ± 267
O2 (mL·min-1·kg-1) 13.11 ± 3.40 14.26 ± 3.55
O2 (% O2 peak) 60.8 ± 9.3* 46.7 ± 7.9
Submaximal relationship
∆ O2/∆WR (mL·min-1·W-1)
S1 7.8 ± 1.4* 9.5 ± 0.8
S2 6.8 ± 1.5* 10.3 ± 0.6
ST 7.4 ± 1.7* 9.9 ± 0.7
O2 KINETICS
MRT1 (s) 56.2 ± 17.4* 47.1 ± 18.0
MRT2 (s) 58.7 ± 19.2* 49.3 ± 17.4
VENTILATORY
Peak exercise
E (L/min) 41.9 ± 17.7* 81.6 ± 20.9
Submaximal relationship
∆ E/∆ CO2 (L/L) 36.5 ± 5.2* 27.3 ± 2.7
CARDIOVASCULAR
Peak exercise
HR (bpm) 157 ± 19* 178 ± 10
HR (% pred) 86.3 ± 8.1* 95.4 ± 4.3
O2/HR (mL·min-1·beat-1) 7.4 ± 3.1* 11.4 ± 3.3
Submaximal relationship
∆HR/∆ O2 (beat·L-1·min-1) 83.0 ± 26.2* 54.4 ± 14.8
Data are reported as means ± SD or median (range). WR = work rate; RER = 
respiratory exchange ratio, O2 = oxygen uptake; MRT = mean response time; 
E = minute ventilation; HR = heart rate; CO2 = carbon dioxide output. *P < 
0.05 (unpaired t-test or Mann-Whitney test).
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Discussion
This study has provided novel evidence that a readily 
available index of “aerobic efficiency” during ramp-incre-
mental cycle ergometer exercise (Δ O2/ΔWR) is typically 
reduced in patients with MM, particularly in the supra-GET 
S2 component. The Δ O2/ΔWR was associated with wors-
ening maximal (peak O2, lactate/WR) and submaximal 
( O2GET) markers of aerobic impairment and reduced 
peripheral muscle performance. In addition, this index was 
inversely related to submaximal cardiopulmonary stress 
(Δ E/Δ CO2 and ΔHR/Δ O2), suggesting that these sys-
tems adopted a hyperdynamic pattern of response to com-
pensate for an impaired O2 utilization. Our data, therefore, 
indicate that Δ O2/ΔWR may constitute a useful submaxi-
mal, effort-independent exercise index for quantification of 
functional impairment in this patient population.
Aerobic impairment and exercise capacity in MM 
patients
For clinical interpretation of Δ O2/ΔWR during rapid-
incremental exercise (ramp), it is important to differentiate 
between this index of aerobic metabolism and the O2-WR 
relationship in response to constant WR exercise (“economy 
of cycling”), which is largely independent of fitness or 
cardiocirculatory dysfunction (1,2). Therefore, Δ O2/ΔWR 
does not directly reflect the efficiency of muscle contraction, 
but rather the relative increase in aerobic metabolism as 
power output is increased. In this context, a reduced, but 
linear, Δ O2/ΔWR is thought to represent decreased O2 
utilization (1,2). Assuming that patients’ ability to increase 
cardiac output was not impaired (see Study limitations), a 
lower C(a-v)O2 (i.e., reduced O2 extraction) is the most likely 
explanation for a reduced Δ O2/ΔWR as demonstrated by 
Taivassalo et al. (19) and, more recently, by Grassi et al. 
(32) using near-infrared spectroscopy. Considering that 
Δ O2/ΔWR was significantly related to several indicators 
of aerobic metabolism, this relationship seems to be useful 
to indicate patients in whom O2 extraction is particularly 
impaired.
In the present study, we found a strong linear relation-
ship between Δ O2/ΔWR and peak O2 in MM patients, 
but not in controls (Figure 2). These results are consistent 
with the notion that the decrease in Δ O2/ΔWR in disease 
conditions associated with impaired O2 delivery or utiliza-
tion may be severe enough to reduce peak O2. This has 
been previously demonstrated by decreasing arterial O2 
content in healthy subjects (33) and in chronic cardiovas-
cular disease (1,6,10).
Determinants of the Δ O2/ΔWR relationship in MM 
patients
Some previous data have demonstrated that a 
Δ O2/ΔWR relationship below the GET (S1) satisfacto-
rily represents the equivalent steady-state O2 response 
(1,2,5,29), even in conditions associated with reduced 
Δ O2/ΔWR (11). For supra-GET exercise, however, the 
O2 response provides an imprecise estimate of the total 
rate of ATP regeneration, since the increased contribution of 
the anaerobic metabolism would contribute significantly to 
the overall muscle energetics. Paradoxically, the observed 
O2 response is characteristically higher than expected 
from the sub-GET O2-WR relationship due to the devel-
opment of an “excessive” O2 response (34). Although the 
determinants of the so-called “slow component” of the O2 
response remain elusive, much of the extra- O2 seems to 
derive from the exercising muscles (∼80%), probably due 
to progressive recruitment of less efficient type II fibers (4). 
In fact, the greater increase in S2 relative to S1 has been 
found in subjects with a high percentage of type II fibers 
and at high pedal rates (5).
In the present study, we confirm previous observations 
that S2 is steeper than S1 in normal subjects, probably 
reflecting the contribution of the O2 slow component 
(2,3,5,29). This pattern, however, contrasted with that 
found in patients with MM who showed a consistently lower 
S2/S1 ratio at the same pedaling rate compared to normal 
subjects. These results were not due to a faster rate of work 
rate incrementation in patients as the ramp duration did not 
differ between patients and controls. Although muscle fiber 
Figure 2. Relationship (Pearson’s product-moment correlation) 
between a submaximal metabolic index of exercise functioning 
(∆ O2/∆WR) and peak aerobic capacity (peak O2) in patients 
with mitochondrial myopathy (closed circles) and normal controls 
(open circles). Note that the lower ∆ O2/∆WR values were sig-
nificantly related to peak O2 in patients but not in controls. In 
addition, a ∆ O2/∆WR below 8 mL·min-1·W-1 was suggestive 
of severe aerobic impairment in MM patients (peak O2 <60% 
predicted) (29). O2 = oxygen consumption; WR = work rate 
(power).
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typing was not performed in the present study, a selective 
reduction in the type II fiber population could be related 
to this phenomenon and/or MM patients may have an im-
paired ability to recruit these fibers (35,36). Alternatively, 
the deleterious heteroplasmic mtDNA alterations may have 
equally affected type I and type II fibers (12). In addition, 
it should be recognized that some of the mechanisms 
involved in the O2 slow component might be linked to 
lactate production and/or metabolism. Considering, there-
fore, that the anaerobic contribution (and lactate release) 
to muscle metabolism is increased in these patients since 
early exercise (16,19), the increase in lactate (and O2) 
above the GET, compared to sub-GET, exercise may have 
been less abrupt in patients than controls. In this context, 
it is interesting to note that similar findings (lower S2/S1) 
were reported in studies involving patients with chronic 
heart failure probably due to impaired O2 delivery (33,37). 
We also cannot rule out the possibility that the supra-GET 
exercise was associated with lower rates of ATP regenera-
tion and further decreases in O2 utilization. Nevertheless, 
peak O2 was particularly related to S2, suggesting that 
the end-exercise O2 response is strongly influenced by 
the magnitude of the supra-GET O2 response in patients 
with reduced Δ O2/ΔWR values. 
Ventilatory and cardiovascular responses to 
incremental exercise in MM
The precise etiology of the hyperventilatory and hyper-
circulatory responses to dynamic exercise in MM patients is 
unknown. Some investigators have postulated a common 
mechanism for these adjustments with a descending parallel 
activation of the respiratory and cardiovascular centers in 
response to afferent stimulation from metabolically sensitive 
chemoreceptors in peripheral skeletal muscles (19,38). Our 
data showing a strong relationship between Δ O2/ΔWR 
and cardiopulmonary stress suggest that these abnormali-
ties can be mechanistically linked. Therefore, heightened 
cardiopulmonary responses could be expected in those 
patients in whom the intramuscular disturbances were more 
pronounced and the afferent stimuli were higher, i.e., those 
with lower Δ O2/ΔWR. This hypothesis, however, should 
be more properly investigated in studies evaluating the 
responses to interventions aimed to improved O2 utilization 
in these patients. Nevertheless, the increased ventilatory 
and cardiovascular costs combined with lower Δ O2/ΔWR 
(S2) seem to indicate that they are not relevant to explain 
the extra- O2 related to heavy exercise in MM patients.
Study limitations
In order to accurately measure the power output, the 
patients were evaluated during incremental cycle ergometry. 
Therefore, our results may not be applicable to body-bearing 
activities, such as walking or running. In addition, although 
patients were screened at rest for significant cardiovascular 
disease, stroke volume was not measured during exertion. 
Consequently, we cannot be sure that our patients were 
“hypercirculatory” as low stroke volume may have limited 
any increase in cardiac output. Moreover, C(a-v)O2 was not 
measured and impaired O2 extraction could only be inferred 
from noninvasive data. Finally, genetic studies were not 
performed and we were unable to correlate the physiological 
abnormalities with mtDNA mutation load on skeletal muscle 
or the qualitative distribution of type fibers (39).
In conclusion, our results indicate that a readily avail-
able, effort-independent submaximal index of aerobic 
dysfunction during ramp-incremental exercise (Δ O2/ΔWR) 
is severely reduced in patients with MM, being related to 
increased functional impairment and higher HR and venti-
latory responses related to metabolism. This relationship, 
therefore, should be routinely reported in cardiopulmonary 
exercise testing evaluations and clinically valued in this 
patient population.
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